AIRLINK 189.45 Increased By ▲ 1.42 (0.76%)
BOP 11.20 Decreased By ▼ -0.66 (-5.56%)
CNERGY 7.29 Decreased By ▼ -0.25 (-3.32%)
FCCL 36.70 Decreased By ▼ -1.09 (-2.88%)
FFL 15.00 Decreased By ▼ -0.24 (-1.57%)
FLYNG 26.39 Increased By ▲ 0.86 (3.37%)
HUBC 131.45 Increased By ▲ 1.30 (1%)
HUMNL 13.50 Decreased By ▼ -0.11 (-0.81%)
KEL 4.27 Decreased By ▼ -0.08 (-1.84%)
KOSM 6.05 Decreased By ▼ -0.12 (-1.94%)
MLCF 45.99 Increased By ▲ 0.31 (0.68%)
OGDC 202.49 Decreased By ▼ -3.94 (-1.91%)
PACE 6.10 Decreased By ▼ -0.28 (-4.39%)
PAEL 38.18 Decreased By ▼ -2.13 (-5.28%)
PIAHCLA 16.81 Decreased By ▼ -0.14 (-0.83%)
PIBTL 7.91 Decreased By ▼ -0.12 (-1.49%)
POWER 9.85 Decreased By ▼ -0.18 (-1.79%)
PPL 173.84 Decreased By ▼ -5.00 (-2.8%)
PRL 34.94 Decreased By ▼ -1.42 (-3.91%)
PTC 24.10 Decreased By ▼ -0.29 (-1.19%)
SEARL 101.80 Decreased By ▼ -1.36 (-1.32%)
SILK 1.06 Decreased By ▼ -0.01 (-0.93%)
SSGC 32.68 Decreased By ▼ -3.56 (-9.82%)
SYM 17.95 Decreased By ▼ -0.28 (-1.54%)
TELE 8.11 Decreased By ▼ -0.27 (-3.22%)
TPLP 12.02 Decreased By ▼ -0.14 (-1.15%)
TRG 67.44 Increased By ▲ 0.11 (0.16%)
WAVESAPP 11.79 Decreased By ▼ -0.22 (-1.83%)
WTL 1.53 Decreased By ▼ -0.04 (-2.55%)
YOUW 3.95 Increased By ▲ 0.06 (1.54%)
BR100 11,819 Decreased By -87.9 (-0.74%)
BR30 35,000 Decreased By -554.1 (-1.56%)
KSE100 112,085 Decreased By -478.8 (-0.43%)
KSE30 34,946 Decreased By -148 (-0.42%)

KARACHI: Haleon Pakistan plans to start manufacturing multivitamin brand Centrum in the country for domestic sales and export, its CEO said, as the company seeks to boost sales amid lower inflation.

The Pakistan unit of British consumer healthcare firm Haleon plans to expand its pain management offerings next year by adding the Panadol range for menstrual pain and migraines, CEO Farhan Muhammad Haroon told Reuters in an interview.

“Pakistan has a Rs24-billion ($86.30 million) Vitamin Mineral Supplement market. This does not include the grey market. We already make up Rs7.5 billion ($26.97 million) of the market through our (vitamin) products CAC-1000 Plus and Qalsium-D,” said Haroon.

“With the launch of Centrum, we plan to capture 7 to 8% of remaining market immediately, which is a sizeable portion of the category.”

Pakistan’s Citi Pharma, Martin Dow partner with Chinese firm for biotech manufacturing

Haroon said the company plans to sell Centrum in smaller bottles so customers do not have to worry about high upfront costs, as purchasing power has diminished in the country after inflation hit a multidecade high of around 40% last year. In November, Pakistan’s consumer price index inflation slowed to 4.9%.

Haroon said in the first stage of the Centrum launch, expected in the first quarter of 2025, the product will be imported, and in the second stage it will be made locally with market specific variants to suit needs of Pakistanis and other export markets.

“We already export our calcium and vitamin D supplement CAC-1000 Plus and topical pain relief product Voltral Emulgel to Vietnam and Philippines, we will be ready to export to 19 countries in the next 1-1.5 years,” he said.

Haleon Pakistan sees at least 10% of its sales coming from exports in the next two years, up from 5%-6% during its peak in 2022, Haroon said, adding that it had invested $10 million last year to enhance local production capabilities.

Comments

200 characters